This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2013 Nov 14;369(20):1960-2.

doi: 10.1056/NEJMe1312286. Epub 2013 Nov 9.

The end of dual therapy with renin-angiotensin-aldosterone system blockade?

Dick de Zeeuw¹

Affiliations

PMID: 24206456
DOI: 10.1056/NEJMe1312286

Editorial

The end of dual therapy with renin-angiotensin-aldosterone system blockade?

Dick de Zeeuw. N Engl J Med. 2013.

. 2013 Nov 14;369(20):1960-2.

doi: 10.1056/NEJMe1312286. Epub 2013 Nov 9.

Author

Dick de Zeeuw¹

Affiliation

¹ From the Department of Clinical Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

PMID: 24206456
DOI: 10.1056/NEJMe1312286

No abstract available

PubMed Disclaimer

Comment on

Combined angiotensin inhibition for the treatment of diabetic nephropathy.
Fried LF, Emanuele N, Zhang JH, Brophy M, Conner TA, Duckworth W, Leehey DJ, McCullough PA, O'Connor T, Palevsky PM, Reilly RF, Seliger SL, Warren SR, Watnick S, Peduzzi P, Guarino P; VA NEPHRON-D Investigators. Fried LF, et al. N Engl J Med. 2013 Nov 14;369(20):1892-903. doi: 10.1056/NEJMoa1303154. Epub 2013 Nov 9. N Engl J Med. 2013. PMID: 24206457 Clinical Trial.

Similar articles

[Dual blockade of the renin-angiotensin system in diabetic patients is dangerous].
Steurer J. Steurer J. Praxis (Bern 1994). 2014 Feb 26;103(5):289-90. doi: 10.1024/1661-8157/a001580. Praxis (Bern 1994). 2014. PMID: 24568766 German. No abstract available.
Serum potassium in dual renin-angiotensin-aldosterone system blockade.
Seliger SL, Fried LF. Seliger SL, et al. Clin J Am Soc Nephrol. 2014 Feb;9(2):219-21. doi: 10.2215/CJN.12411213. Epub 2014 Jan 9. Clin J Am Soc Nephrol. 2014. PMID: 24408119 Free PMC article. No abstract available.
Combined angiotensin inhibition in diabetic nephropathy.
Nikolaidou B, Lazaridis A, Doumas M. Nikolaidou B, et al. N Engl J Med. 2014 Feb 20;370(8):778-9. doi: 10.1056/NEJMc1315504. N Engl J Med. 2014. PMID: 24552332 No abstract available.
[Progress on the drug therapy for diabetic microangiopathies: RA system inhibitor].
Higashiura K, Shimamoto K. Higashiura K, et al. Nihon Rinsho. 2005 Jun;63 Suppl 6:144-9. Nihon Rinsho. 2005. PMID: 15999698 Review. Japanese. No abstract available.
Renal effects of dual renin-angiotensin-aldosterone system blockade in patients with diabetic nephropathy.
Dalla Vestra M, Simioni N, Masiero A. Dalla Vestra M, et al. Int Urol Nephrol. 2009;41(1):119-26. doi: 10.1007/s11255-008-9490-0. Epub 2008 Oct 29. Int Urol Nephrol. 2009. PMID: 18958580 Review.

See all similar articles

Cited by

A Qualitative Scoping Review of Early-Terminated Clinical Trials Sponsored by the Department of Veterans Affairs Cooperative Studies Program From 2010 to 2020.
Goldberg A, Bakhireva LN, Page K, Henrie AM. Goldberg A, et al. Epidemiol Rev. 2022 Dec 21;44(1):110-120. doi: 10.1093/epirev/mxac009. Epidemiol Rev. 2022. PMID: 36193844 Free PMC article. Review.
Implications of Guideline Updates for the Management of Apparent Treatment Resistant Hypertension in the United States (A NCDR Research to Practice [R2P] Project).
Maw AM, Thompson LE, Ho PM, Kennedy KF, Maddox TM, Valle JA, Sandhu A, Masoudi FA, Messerli FH, Daugherty SL. Maw AM, et al. Am J Cardiol. 2020 Jan 1;125(1):63-67. doi: 10.1016/j.amjcard.2019.09.033. Epub 2019 Oct 11. Am J Cardiol. 2020. PMID: 31727262 Free PMC article.
The Effects of Novel Antidiabetic Drugs on Albuminuria in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Luo Y, Lu K, Liu G, Wang J, Laurent I, Zhou X. Luo Y, et al. Clin Drug Investig. 2018 Dec;38(12):1089-1108. doi: 10.1007/s40261-018-0707-4. Clin Drug Investig. 2018. PMID: 30255388
Renin-angiotensin-aldosterone system blockade in chronic kidney disease: current strategies and a look ahead.
Viazzi F, Bonino B, Cappadona F, Pontremoli R. Viazzi F, et al. Intern Emerg Med. 2016 Aug;11(5):627-35. doi: 10.1007/s11739-016-1435-5. Epub 2016 Mar 17. Intern Emerg Med. 2016. PMID: 26984204 Review.
Combination use of medicines from two classes of renin-angiotensin system blocking agents: risk of hyperkalemia, hypotension, and impaired renal function.
Esteras R, Perez-Gomez MV, Rodriguez-Osorio L, Ortiz A, Fernandez-Fernandez B. Esteras R, et al. Ther Adv Drug Saf. 2015 Aug;6(4):166-76. doi: 10.1177/2042098615589905. Ther Adv Drug Saf. 2015. PMID: 26301070 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information